SARAH STORNIOLO: Open Payments
NPI 1215554068 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,728 in 26 payments from 11 companies in 2025. Trend: 2023 $303 · 2024 $860 · 2025 $2,728
Food & beverage: $2,580Education: $148
| Company | Payments | Amount |
|---|---|---|
| Lumenis BE inc | 1 | $1,823 |
| ABBVIE INC. | 7 | $346 |
| Janssen Biotech, Inc. | 7 | $150 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $149 |
| GENZYME CORPORATION | 2 | $69 |
| LEO Pharma Inc. | 2 | $67 |
| Lilly USA, LLC | 1 | $31 |
| Galderma Laboratories, L.P. | 1 | $30 |
| Solta Medical, a division of Bausch Health US, LLC | 1 | $24 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $20 |
Products named: M22, BOTOX, TREMFYA, SKYRIZI, DUPIXENT, ANZUPGO, RINVOQ, ILUMYA.
Industry payments across CA — which companies pay providers there.
